By using our site you consent to the CTFN Privacy Policy, Cookies Policy, and Terms of Service.
The group of Takeda minority shareholders known as Thinking about Takeda’s Bright Future (TTBF) is focusing all its efforts on talking to domestic institutions such as life insurance companies into voting against the acquisition of Shire featured
On October 26 Takeda announced it had proposed a remedy to the European Commission of selling Shire’s SHP647, a pipeline compound for the treatment of inflammatory bowel disease, which will potentially compete with Takeda’s marketedfeatured
AET/CVS Opening the October 18 public hearing before the New York Department of Financial Services on the Aetna/CVS merger, DFS Superintendent Maria Vullo noted that her agency has approval authority over only one Aetna subsidiary, but then went on to elaborate how DFS touches various Aetna and CVS businesses in New York, particularly through license … Read Morefeatured
Takeda expects to hear from the European Commission by the end of the week regarding potential concerns the commission might have with Takeda’s acquisition of Shire, a source close to the situation told CTFN.featured
AET/CVS On the sidelines of the Connecticut Insurance Department Form A hearing regarding CVS Health’s $69 billion acquisition of Aetna, CVS general counsel Tom Moriarty told CTFN the parties are making good progress with the pending antitrust review with the Department of Justice, and “are almost there.” SHPG/4502:JP Chances that the group of Takeda minority … Read Morefeatured
Chances that the group of Takeda minority shareholders opposing the Japanese drug maker’s planned acquisition of rival Shire will succeed in blocking the deal appear to be low, local sources told CTFN.featured
Updated at 12:25pm While CTFN originally expected Takeda to miss the end of September deadline for its EC filing by a few days, Takeda today filed with the EC its merger with Shire with a provisional deadline of November 6, 2018.featured
Japanese drugmaker Takeda is considering selling some of Shire’s divisions once it finalizes its takeover of the Irish peer.featured
The Federal Communications Commission has conundrums it must confront before it is ready to issue an order on the national television reach cap and begin examining other radiofeatured
A group of minority shareholders of Japanese drug company Takeda will carry out a review of Shire’s R&D pipeline to prove that even the most promising business areas wouldfeatured
Simply fill out the form below and one of our representatives will be in touch.